Successfully addressing issues with the magnitude of primary aldosteronism requires coordinated efforts across the entire healthcare system.
Improving the standards of care of a highly prevalent disease that disproportionately affects some segments of a population requires public health interventions.
If 95% of those affected are neither diagnosed nor treated, interventions are also needed to ensure the provision and insurance coverage of health services:
- Payment structures must allow for all diagnostic and treatment procedures for all patients,
- Guidelines’ uptake must be facilitated by timely updates and knowledge translation,
- Targeted research must be funded proportionally to the number of affected patients,
- Curriculum must be revised at all teaching institutions to equip physicians with the means to recognize and treat the disease,
- Barriers to diagnosis and treatment must be identified, and inclusive solutions implemented at the primary and specialized care levels,
- Accurate screening must be undertaken on a large scale, and
- Capacity must be increased at all medical centers to address unmet medical needs.
To design and implement the needed interventions, the Foundation advocates leveraging scientific power through the creation of a multi-stakeholders’ alliance.
In the short term, the Foundation is prioritizing its programs to help address some of the most pressing issues with interventions expected to yield the greatest return on investment. These programs involve: